Eventide Healthcare & Life Sciences Fd Cl I (ETIHX) has a profit margin of 63.66%, above the sector sector average of 13.4%.
Get informed when a big investor buys or sells
+ FollowAs of Dec 2023
Trailing 12 months ending Dec 2023
Eventide Healthcare & Life Sciences Fd Cl I (ETIHX) currently reports a profit margin of 63.66% as of December 2023. That compares with 967.88% in the prior-year period — down 93.4% year over year. That is above the sector sector average of 13.4%. Use the charts on this page to explore Eventide Healthcare & Life Sciences Fd Cl I's profit margin history and peer comparisons.
Eventide Healthcare & Life Sciences Fd Cl I's profit margin decreased from 967.88% to 63.66% — a 93.4% year-over-year decrease (period ending December 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Eventide Healthcare & Life Sciences Fd Cl I's profit margin of 63.66% is higher than the its sector sector average of 13.4%. That is roughly 374.9% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' profit margin, but Eventide Healthcare & Life Sciences Fd Cl I's current 63.66% should be judged against industry norms (sector average: 13.4%) and against ETIHX's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current profit margin of 63.66%, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is 13.4%. From there, open related valuation or income-statement pages for Eventide Healthcare & Life Sciences Fd Cl I, and consider following ETIHX for alerts when major investors trade the stock.